Literature DB >> 2945438

Laminin production by human endometrial stromal cells relates to the cyclic and pathologic state of the endometrium.

M Faber, U M Wewer, J G Berthelsen, L A Liotta, R Albrechtsen.   

Abstract

The cyclic changes in the presence of the basement membrane glycoprotein laminin in endometrial stromal cells was studied by immunohistochemistry. The interstitial matrix around the stromal cells of the proliferative phase of the normal menstrual cycle was unreactive with antibodies to laminin. However, commencing with the secretory phase, stromal cells accumulated distinct cytoplasmic and pericellular laminin-immunoreactive material. The maximal amount of stromal cell-associated laminin was observed in predecidual cells of the late secretory phase. Thus, laminin immunostaining discriminates stromal cells of the proliferative phase (being "negative") from those in the secretory phase (being "positive"). Sixty-six cases of endometrial hyperplasia and adenocarcinomas were also stained with antibodies to laminin. Sixty-nine percent of biopsies of cystic hyperplasia and 30% of adenomatous hyperplasia contained laminin-positive stromal cells. Ultrastructural examination of stromal cells in cystic hyperplasia revealed the presence of pericellular basement membrane-like material, focally arranged into typical lamina rara and lamina densa. In contrast, stromal cells in the atypical adenomatous hyperplasia and adenocarcinomas did not react with antibody to laminin. The expression of laminin receptor in the stromal cells codistributed with laminin. Basement membranes of the surface epithelium, the glandular epithelium, and the vessels stained strongly with antibodies to laminin. In preneoplastic and neoplastic tissues, laminin immunostaining revealed discontinuous and defective basement membranes. In poorly differentiated carcinomas only sparse amounts of laminin-positive basement membrane were observed; these tumors, in contrast, exhibited cytoplasmic laminin and also significant immunoreaction with antibodies to laminin receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2945438      PMCID: PMC1888352     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Laminin--a glycoprotein from basement membranes.

Authors:  R Timpl; H Rohde; P G Robey; S I Rennard; J M Foidart; G R Martin
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

2.  Estradiol and progesterone receptors in normal and neoplastic endometrium: correlations between receptors, histopathological examinations and clinical responses under progestin therapy.

Authors:  P M Martin; P H Rolland; M Gammerre; H Serment; M Toga
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

3.  Modifications of the human endometrial fine structure induced by low-dose progestogen therapy.

Authors:  C A Maruffo; F Casavilla; B van Nynatten; V Perez
Journal:  Fertil Steril       Date:  1974-09       Impact factor: 7.329

4.  Immunoperoxidase localisation of fibronectin in glomeruli of formalin fixed paraffin processed renal tissue.

Authors:  J Burns; A J Dixon; J C Woods
Journal:  Histochemistry       Date:  1980

5.  Characterization of a rat yolk sac carcinoma cell line.

Authors:  U Wewer
Journal:  Dev Biol       Date:  1982-10       Impact factor: 3.582

6.  Prolactin production by human endometrium during the normal menstrual cycle.

Authors:  I A Maslar; D H Riddick
Journal:  Am J Obstet Gynecol       Date:  1979-11-15       Impact factor: 8.661

7.  Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases.

Authors:  B A Gusterson; M J Warburton; D Mitchell; M Ellison; A M Neville; P S Rudland
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

8.  Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma.

Authors:  R J Kurman; H J Norris
Journal:  Cancer       Date:  1982-06-15       Impact factor: 6.860

9.  Basement membrane changes in breast cancer detected by immunohistochemical staining for laminin.

Authors:  R Albrechtsen; M Nielsen; U Wewer; E Engvall; E Ruoslahti
Journal:  Cancer Res       Date:  1981-12       Impact factor: 12.701

10.  Galloylglucoses of low molecular weight as mordant in electron microscopy. I. Procedure, and evidence for mordanting effect.

Authors:  N Simionescu; M Simionescu
Journal:  J Cell Biol       Date:  1976-09       Impact factor: 10.539

View more
  7 in total

Review 1.  Use of basement membrane markers in tumour diagnosis.

Authors:  A J d'Ardenne
Journal:  J Clin Pathol       Date:  1989-05       Impact factor: 3.411

2.  An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and first trimester of pregnancy.

Authors:  J D Aplin; A K Charlton; S Ayad
Journal:  Cell Tissue Res       Date:  1988-07       Impact factor: 5.249

3.  Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane.

Authors:  U M Wewer; R Albrechtsen; L W Fisher; M F Young; J D Termine
Journal:  Am J Pathol       Date:  1988-08       Impact factor: 4.307

4.  Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor.

Authors:  Jemma Evans; Rob D Catalano; Pamela Brown; Rob Sherwin; Hilary O D Critchley; Asgerally T Fazleabas; Henry N Jabbour
Journal:  FASEB J       Date:  2009-03-02       Impact factor: 5.191

5.  Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.

Authors:  Pradeep S Tanwar; Tomoko Kaneko-Tarui; Lihua Zhang; Yoshihiro Tanaka; Christopher P Crum; Jose M Teixeira
Journal:  PLoS Genet       Date:  2012-08-16       Impact factor: 5.917

6.  Morphological and immunohistochemical diversity of endometrial stromal sarcoma in rats.

Authors:  Shino Kumabe; Junko Sato; Yuki Tomonari; Miwa Takahashi; Kaoru Inoue; Midori Yoshida; Takuya Doi; Yumi Wako; Minoru Tsuchitani
Journal:  J Toxicol Pathol       Date:  2018-02-02       Impact factor: 1.628

7.  Therapeutic evaluation of sclerotherapy for limb venous malformations: A case series.

Authors:  Tenghui Zhan; Fanggang Cai; Pingfan Guo; Yujie Lian; Hui Zhuang; Jinchi Zhang; Hongyu Chen; Cheng Chen; Yichen Lin
Journal:  Phlebology       Date:  2020-05-29       Impact factor: 1.740

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.